Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Merck Animal Health Receives U.S. FDA Approval of Expanded Indication for BRAVECTO Chews for Dogs
Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, […]
Sharecare Launches VR Program to Improve Well-being of American Workforce
Sharecare, the digital health company that helps people manage all their health in one place, […]
Cell BioEngines Enters into an Exclusive Worldwide Agreement to Develop and Commercialize Potent Immune Cell States to Cure Cancer
Cell BioEngines, a cell and gene therapy company focused on developing an allogenic cell-based product […]
Nogra Pharma Announces Out-licensing Agreement with Torii Pharmaceutical for Japan for New Chemical Entity Topical Acne Treatment
Nogra Pharma, a clinical-stage biotechnology company developing innovative therapeutics for immune-inflammatory-mediated diseases, today announces it […]
Cerebral Therapeutics Names Julie Foster as Chief Operating Officer
Cerebral Therapeutics, a clinical-stage pharmaceutical company pioneering therapies for neurological diseases, announced today the appointment […]
Curapath Receives Accreditation as a GMP Investigational Drug Product Manufacturer from the Spanish Agency for Medicine and Health Products
Curapath, a leader in the design, development, and custom manufacturing of polyamino-acid and lipid nanoparticle […]
Daewoong Pharmaceutical Submitted NDA for its Global New Drug Fexuclue in 11 Countries
Fexuclue from Daewoong Pharmaceutical is attracting attention as a game changer in the global gastroesophageal […]
Roche launches COVID-19 PCR Test to Detect the Fast Spreading XBB.1.5 Omicron Sub-variant
Roche and its subsidiary TIB Molbiol have developed a COVID-19 PCR test for researchers that […]
ProPharma Acquires UK Based Digital Lab Consulting
ProPharma Group (ProPharma) the leading global provider of regulatory, clinical, and quality services for the […]
New Initiative Aims to Reverse the Alarming Rise in Cardiovascular Deaths
The number of cardiovascular deaths is on the rise again after a decades-long decline. As […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more